Alembic Pharmaceuticals Limited — Board Meeting, 04-08-2026: Outcome of Board Meeting
04-08-2026 | 02:05 pm
04-08-2026 | 02:05 pm
Alembic Pharmaceuticals' Board approved Q1 financial results. Consolidated Revenue from Operations stood at ₹2,149.77 Cr, with Net Profit at ₹175.33 Cr for the quarter. EPS was ₹8.80.
No comments yet. Be the first to comment!
